Table 2.
Characteristics of the study population
| n | 204 |
| Age, years (SD) | 67.2 (13.8) |
| Female sex (%) | 64 |
| Diabetes (%) | 8.7 |
| Current smokers (%) | 5 |
| History of ischemic heart disease (%) | 3.2 |
| History of cerebrovascular diseasea (%) | 3.4 |
| BMI, kg/m2 (SD) | 28.9 (5.4) |
| Office SBP, mmHg (SD) | 140.9 (17.1) |
| Office DBP, mmHg (SD) | 78 (9.7) |
| Home SBP, mmHg (SD)b | 134.1 (13.9) |
| Home DBP, mmHg (SD)b | 73.8 (8.8) |
| Number of antihypertensive drugs (SD) | 2.1 (1.2) |
| FPG, mg/dL (SD) | 101.4 (17.8) |
| eGFR, mL/min/1.73 m2 (SD) | 81.7 (20.3) |
| SCr, mg/dL (SD) | 0.88 (0.24) |
| Total cholesterol, mg/dL (SD) | 187.5 (34.2) |
| LVMI, g/m2 (SD) | 95 (22.1) |
| Ejection fraction, % (SD) | 57 (3.7) |
| Relative wall thickness (SD) | 0.44 (0.06) |
| Carotid-femoral pulse wave velocity, m/s (SD) | 9.3 (2.4) |
BMI body mass index, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, FPG fasting plasma glucose, LVMI left ventricular mass index, m/s meters per second, SBP systolic blood pressure, Scr serum creatinine, SD standard deviation
aStroke or transient ischemic attack.
bAverage of all BP measurements from the 4-day monitoring.